Showing results (581-590 of 703) with videos related to
Sort By:
Pageof 71
Journal of Immunology (Baltimore, Md. : 1950)|July 29, 2009
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cellsOren Hershkovitz, Benyamin Rosental, Lior Ann Rosenberg, et al.Advanced Materials (Deerfield Beach, Fla.)|November 29, 2025
Potent Liver-Tropic mRNA Lipid Nanoparticles: ApoE-Mediated Delivery Through a Low-Density Lipoprotein Receptor Independent Uptake MechanismAshish Sarode, Christian Ortiz, Tadeh Derstepanian, et al.Nature|May 12, 2021
SARS-CoV-2 uses a multipronged strategy to impede host protein synthesisYaara Finkel, Avi Gluck, Aharon Nachshon, et al.Journal of Neurology|September 10, 2014
Costeff syndrome: clinical features and natural historyGilad Yahalom, Yair Anikster, Ruth Huna-Baron, et al.Biomarkers in Cancer|December 11, 2013
An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer DiagnosisGalit Yahalom, Daria Weiss, Ilya Novikov, et al.Plos One|May 20, 2016
Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Liron Tuval-Kochen, David Castel, et al.Vaccines|May 25, 2024
Induction of Superior Systemic and Mucosal Protective Immunity to SARS-CoV-2 by Nasal Administration of a VSV-ΔG-Spike VaccineYfat Yahalom-Ronen, Sharon Melamed, Boaz Politi, et al.Plos One|August 23, 2016
Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug CombinationsMichal Yalon, Liron Tuval-Kochen, David Castel, et al.Nature Communications|April 16, 2024
Synergistic effect of two human-like monoclonal antibodies confers protection against orthopoxvirus infectionHadas Tamir, Tal Noy-Porat, Sharon Melamed, et al.Nature|September 9, 2020
The coding capacity of SARS-CoV-2Yaara Finkel, Orel Mizrahi, Aharon Nachshon, et al.Pageof 71